Advertisement
CRISPR Therapeutics Says FDA Grants RMAT Designation To CTX130
(RTTNews) - Biopharmaceutical company CRISPR Therapeutics (CRSP) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX130, the Company's wholly-owned allogeneic CAR T cell therapy targeting CD70, for the treatment of Mycosis Fungoides and Sézary Syndrome (MF/SS).
Established under the 21st Century Cures Act, RMAT designation is a dedicated program designed to expedite the drug development and review processes for promising pipeline products, including genetic therapies.
Similar to Breakthrough Therapy designation, RMAT designation provides the benefits of intensive FDA guidance on efficient drug development.
For More Such Health News, visit rttnews.com
read more
Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology
Biotechnology company Vertex Pharmaceuticals, Inc. (VRTX) and gene editing company CRISPR Therapeutics, Inc. (CRSP) announced Monday that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics' gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex's hypoimmune cell therapies for type 1 diabetes (T1D).
RTTNews
|
739 days ago
Sensex Tumbles 930 Points Amid Global Selloff; Nifty Nears 22,900
Indian shares fell sharply on Friday as U.S. President Donald Trump's broad tariff announcements stoked fears about the outlook for inflation and global growth.
RTTNews
|
4h 13min ago
Pound Falls As European Shares Extend Losses On Growth Worries
The British pound weakened against other major currencies in the European session on Friday, as European shares traded lower, extending steep losses from the previous session after U.S. President Donald Trump announced significantly harsher-than-expected tariffs.
RTTNews
|
4h 40min ago
DAX Down 2.2% As Stocks Extend Recent Plunge
After suffering its worst setback in about eight months on Thursday, the German market is deep down in negative territory again with stocks reeling under a fresh bout of selling pressure on Friday amid concerns about growth following U.S. President Donald Trump's tariff moves.
RTTNews
|
4h 44min ago
Pound Falls Against Majors
The British pound weakened against other major currencies in the European session on Friday.
RTTNews
|
5h 22min ago
European Shares Extend Losses On Growth Worries
European shares traded lower on Friday, extending steep losses from the previous session after U.S. President Donald Trump announced significantly harsher-than-expected tariffs.
RTTNews
|
5h 26min ago
Asian Shares Extend Losses In Thin Holiday Trade
Asian stocks extended losses in thin trade on Friday, with markets in mainland China, Hong Kong and Taiwan closed for Tomb Sweeping Day holiday.
RTTNews
|
5h 55min ago
Indian Rupee Rises To Near 4-month High Amid Trump's Reciprocal Tariffs
The Indian rupee strengthened against the U.S. dollar in the early European session on Friday, as a weakening dollar, plunging oil prices and expectations for accelerated Federal Reserve interest-rate cuts supported the INR.
RTTNews
|
6h 22min ago
